Crisaborole

CAS 906673-24-3 11 FDA-DMF suppliersSmall Molecule

Overview

Crisaborole is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL484785).

API suppliers (5)

Suppliers of Crisaborole backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • OPTIMUS DRUGS PRIVATE LTD1 active DMF
  • TAPI NL BV1 active DMF
  • TAPI NL BV1 active DMF
  • OPTIMUS DRUGS PRIVATE LTD1 active DMF
  • HONOUR LAB LTD1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Crisaborole expires 19 Jul 2030 and exclusivity 2 Apr 2026. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name
4-[(1-hydroxy-3H-2,1-benzoxaborol-5-yl)oxy]benzonitrile
Canonical SMILES
B1(C2=C(CO1)C=C(C=C2)OC3=CC=C(C=C3)C#N)O
InChIKey
USZAGAREISWJDP-UHFFFAOYSA-N

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo